1,987
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Clinical outcomes, quality of life, and costs evaluation of peritoneal dialysis management models in Shanghai Songjiang District: a multi-center and prospective cohort study

, , , , , , , , , , , , , , , , & show all
Pages 754-765 | Received 29 Dec 2020, Accepted 10 Apr 2021, Published online: 29 Apr 2021

References

  • Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252.
  • Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13(2):104–114.
  • Coresh J. Update on the burden of CKD. J Am Soc Nephrol. 2017;28(4):1020–1022.
  • Detournay B, Simon D, Guillausseau PJ, et al. Chronic kidney disease in type 2 diabetes patients in France: prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes. Diabetes Metab. 2012;38(2):102–112.
  • Eckardt KU, Coresh J, Devuyst O, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158–169.
  • Jha V, Wang AY, Wang H. The impact of CKD identification in large countries: the burden of illness. Nephrol Dial Transplant. 2012;27(3):32–38.
  • Wang V, Vilme H, Maciejewski ML, et al. The economic burden of chronic kidney disease and end-stage renal disease. Semin Nephrol. 2016;36(4):319–330.
  • Garcia-Garcia G, Jha V. Chronic kidney disease in disadvantaged populations. Curr Opin Nephrol Hypertens. 2015;24(3):203–207.
  • Feder J, Nadel MV, Krishnan M. A matter of choice: opportunities and obstacles facing people with ESRD. Clin J Am Soc Nephrol. 2016;11(3):536–538.
  • Li PK, Chow KM, Van de Luijtgaarden MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90–103.
  • Teerawattananon Y, Mugford M, Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value Health. 2007;10(1):61–72.
  • Mushi L, Krohn M, Flessa S. Cost of dialysis in Tanzania: evidence from the provider’s perspective. Health Econ Rev. 2015;5(1):28.
  • Chang YT, Hwang JS, Hung SY, et al. Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Sci Rep. 2016;6:30266.
  • Bavanandan S, Ahmad G, Teo AH, et al. Budget impact analysis of peritoneal dialysis versus conventional in-center hemodialysis in Malaysia. Value Health Reg Issues. 2016;9:8–14.
  • Okpechi IG, Rayner BL, Swanepoel CR. Peritoneal dialysis in Cape Town, South Africa. Perit Dial Int. 2012;32(3):254–260.
  • Kraus MA, Fluck RJ, Weinhandl ED, et al. Intensive hemodialysis and health-related quality of life. Am J Kidney Dis. 2016;68(5s1):S33–S42.
  • Catheterization C. Chinese guidelines for peritoneal dialysis catheterization. Chinese J Nephrol. 2016;32(11):867–871.
  • Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508.
  • Szeto CC, Li PK, Johnson DW, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 2017;37(2):141–154.
  • Hiramatsu T, Okumura S, Asano Y, et al. Quality of life and emotional distress in peritoneal dialysis and hemodialysis patients. Ther Apher Dial. 2020;24(4):366–372.
  • Nagasawa H, Sugita I, Tachi T, et al. The relationship between dialysis patients’ quality of life and Caregivers’ quality of life. Front Pharmacol. 2018;9:770.
  • McHorney CA, Ware JE, Jr., Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247–263.
  • McHorney CA, Ware JE, Jr., Lu JF, et al. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32(1):40–66.
  • Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
  • Piraino B, Bernardini J, Brown E, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int. 2011;31(6):614–630.
  • Blake PG, Bargman JM, Brimble KS, et al. Clinical practice guidelines and recommendations on peritoneal dialysis adequacy 2011. Perit Dial Int. 2011;31(2):218–239.
  • Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010;30(4):393–423.
  • National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(3):S1–S201.
  • Jiang Z, Yu X. Advancing the use and quality of peritoneal dialysis by developing a peritoneal dialysis satellite center program. Perit Dial Int. 2011;31(2):121–126.
  • Yu X, Yang X, Huang N. Management of a rapidly growing peritoneal dialysis population at the First Affiliated Hospital of Sun Yat-sen University. Perit Dial Int. 2014;34(2):31–34.
  • Wong CKH, Chen J, Fung SKS, et al. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis. Nephrol Dial Transplant. 2019;34(9):1565–1576.
  • Purnell TS, Auguste P, Crews DC, et al. Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am J Kidney Dis. 2013;62(5):953–973.
  • Wang TJ, Lin MY, Liang SY, et al. Factors influencing peritoneal dialysis patients’ psychosocial adjustment. J Clin Nurs. 2014;23(1–2):82–90.
  • Ozcan H, Yucel A, Avşar UZ, et al. Kidney transplantation is superior to hemodialysis and peritoneal dialysis in terms of cognitive function, anxiety, and depression symptoms in chronic kidney disease. Transplant Proc. 2015;47(5):1348–1351.
  • Stasiak CE, Bazan KS, Kuss RS, et al. Prevalence of anxiety and depression and its comorbidities in patients with chronic kidney disease on hemodialysis and peritoneal dialysis. J Bras Nefrol. 2014;36(3):325–331.
  • Fry CE, Nikpay SS, Leslie E, et al. Evaluating community-based health improvement programs. Health Aff. 2018;37(1):22–29.
  • Landon BE, Hicks LS, O’Malley AJ, et al. Improving the management of chronic disease at community health centers. N Engl J Med. 2007;356(9):921–934.